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Introduction
Neurofibromatosis type 1 (NF1), known as von
Recklinghausen’s disease, is the most common familial
disease, with a prevalence of 1/3000, characterized by
the presence of  peripheral nerve tumors.
NF1 gene, located in 17q11.2, produces a protein
named neurofibromina, whose action consists in di-
sfunction of p21-ras oncogene (1-5).
Variety in clinical presentation represents one of the
most important clinical issues in NF1, partially solved
by classification of diagnostic criteria defined in 1987
by the American National Institute of Health (NHI)
Consensus Development Conference (Tab. 1) (6).
Skin neurofibromas, rare in childhood, increase in
number by the age, whereas cafè au lait spots, often the
first clinical manifestation, decrease after fifties. In pa-
tients affected by NF1 clinical status deterioration is
most frequently associated to skeletal disease, neopla-
sias, neurological disorders and plexiform neurofibro-
mas. In addition to cutaneous neurofibromas, patients
with NF1 may develope benign and even malignant
neoplasms, including intestinal tumors, malignant
gliomas, juvenile chronic myeloid leukemia and tu-
mors of neuroectodermal origin, such as pheochro-
mocytoma (7-9).
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Introduction - Neurofibromatosis type 1 (NF1), known as von
Recklinghausen’s disease, is characterized by presence of café au lait
spots, and neurofibromas in the skin or along the course of peripheral
nerves. Diagnosis, despite  extreme clinical  variability, is defined by
established diagnostic criteria. Clinical status is frequently complicated
by systemic disorders and neoplasias.
Case report - A case of a patient affected by NF1, with hyperten-
sion due to adrenal pheochromocytoma and with jejunal neurofibro-
ma, is reported. 
Discussion and conclusions - Variability in clinical presentation
of NF1 with possible manifestation of severe systemic benign and ma-
lignant diseases requires strict follow-up and specific screening of extra-
cutaneous lesions.
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Introduzione - La neurofibromatosi tipo 1 (NF1), conosciuta co-
me malattia di von Recklinghausen, è caratterizzata dalla presenza di
macchie caffelatte e neurofibromi cutanei o lungo il decorso dei nervi
periferici. La diagnosi è codificata da precisi criteri. Il quadro clinico
è spesso complicato da neoplasie o disordini sistemici.
Case report - Gli Autori presentano il caso di un paziente affetto
da NF1 con ipertensione secondaria alla presenza di feocromocitoma
surrenalico e con neurofibroma digiunale.
Discussione e conclusioni - La variabilità nella presentazione
clinica della NF1, con possibili manifestazioni sistemiche e neoplasie,
richiede uno stretto follow-up e screening specifici per eventuali malat-
tie extra-cutanee.
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Patients followed up for NF1 in the Department of
Cutaneous Diseases and Plastic Surgery, University of
Rome “La Sapienza”, undergo regular screening for
early diagnosis of general disorders. Annual follow up
is carried out by clinical examination, whereas
ophthalmologic and psychiatric evaluation is provided
for younger patients. Specific imaging (CT-scan, MR
imaging) and consultation are performed in case of su-
spicion of systemic involvement.
The Authors report a case of association of NF1,
left adrenal pheochromocytoma and jejunal neurofi-
broma causing sub-clinical intestinal stenosis.
Case report
A 42-years-old male patient has been followed up with diagno-
sis of NF1 with typical cutaneous neurofibromas (Fig. 1) since 38
in the Department of Cutaneous Diseases and Plastic Surgery of
the University of Rome “La Sapienza”.
During the last clinical examination the patient, due to symp-
tomatic tachycardia, underwent ECG which showed sinusal tachy-
cardia (105 heart rate/min), and elevated blood pressure in supine
position (145/90 mmHg). Therefore the patient was referred to
the Day Hospital of  Internal Medicine and Hypertension of the
Department of Clinical Sciences. On admission, the blood pres-
sure was 140/90 mmHg and 125/75 mmHg in upright position.
Ambulatory monitoring of blood pressure (AMBP) revealed pa-
roxistic hypertension (180/115 mmHg) without night-time drop
< 10% (not-dipper). Dosage of urinary vanillyl mandelic acid
(12 mg/24h, normal range 1-11), plasma chromogranin-A (152
µg/ml, normal value < 90) and of urinary methanephrines (480
mg/24h, normal range 20-345) indicated high suspicion of
pheochromocytoma. On the other side the patient showed nor-
mal values of calcium and phosphorus, of the hypotalamic-hy-
pophysis-adrenal hormones (ACTH 17.6 pg/ml, cortisol 18
mg/ml, aldosterone 44.3 pg/ml, plasmatic renin activity 0.98
ng/ml/h) and normal thyroid function. 
Based on the considerations above the patient underwent ab-
dominal magnetic resonance (Fig. 2), which demonstrated a
15x12 mm nodule, located at the level of  the left adrenal gland.
This was confirmed by MIBG-scan (Fig. 3). 
After adequate pre-treatment with α- and β-blockers (doxa-
zosin 4 mg/day and propanolol 40 mg/day) the patient un-
derwent left adrenalectomy through median laparotomy. During
surgical exploration a spherical 3.5 cm large neoplasm, involving
the first portion of jejunum (Fig. 4), which appeared compres-
sed, was found. Since tight junction to the bowel, an en-bloc
short jejunal resection was performed with hand-sewn end-to-
end anastomosis. 
Pathologic examination showed respectively adrenal pheoch-
romocytoma and jejunal neurofibroma. 
The immediate postoperative course ran regularly and the
patient was discharged from the hospital on the 10th day. After
four months the patient is doing well, with normal blood pressu-
re and hearth rate, normal blood pressure rythm, as well as dosa-
ge of urinary vanillyl mandelic acid (6.5 mg/24h), plasma chro-
mogranin-A (56 µg/ml) and of urinary methanephrines (256
mg/24h).Fig. 1 - Cutaneous neurofibromas.
Fig. 2 - MR demonstrates enlargement of left adrenal gland.
TABLE 1 - DIAGNOSTIC CRITERIA NATIONAL INSTITUTE
OF HEALTH CONSENSUS DEVELOPMENT CONFEREN-
CE 1987. NEUROFIBROMATOSIS: CONFERENCE STATE-
MENT (ref. 6).
1 Six or more cafè au lait spots 
( 5 mm in children,  15 mm in adults)
2 Two or more neurofibromas of different type 
or a plexiform neurofibroma
3 Axillary or inguinal lentigines
4 Glioma of the nervus opticus
5 One or more Lisch’s nodules
6 Bone disorders
7 Familiarity for NF1 diagnosed as above
Discussion
NF1 is a common autosomal dominant disorder,
characterised by the presence of cafè au lait spots, pe-
ripheral neurofibromas, Lisch’s nodules and freckling.
Diagnosis of NF1, although difficult for the extreme
variability in clinical presentation, is nowadays defined
by presence of at least two of the diagnostic criteria esta-
blished by the National Institute of Health Consensus
Development Conference in 1987 (6). As well it has
been suggested that the clinical behaviour of NF1 may
be graded in four levels, from minimal to severe com-
promised clinical status. Indeed from simple localized
cutaneous or nerve lesions, NF1 may present orthopae-
dic or neurological disorders up to neoplastic diseases.
Since increased frequency of malignancy, NF1 is
burdened by increased mortality compared to general
population. Chronic myeloid leukaemia, neurofibro-
sarcoma, Vater’s ampulla carcinoma, non-Hodgkin
lymphoma, lymphoblastic leukaemia, and rabdomio-
sarcoma are the most frequent neoplasias described as-
sociated to NF1 (7, 15). Furthermore other rare tu-
mors as pheochromocytoma have been found in pa-
tients with NF1 (7-14). 
In 1910 Suzuki first recognized the association of
pheochromocytoma to von Recklinghausen’s disease
(15), which has been reported by many authors in iso-
lated cases. The estimated prevalence of pheochro-
mocytoma in NF1 is between 0.1% and 5.7%, but
this tumor has been found at autopsy in 3.3-13% of
NF1 patients (16)  The mean age at diagnosis of pheo-
chromocytoma in these patients was 42 years, with bi-
lateral adrenal involvement in 9.6% and ectopic pheo-
chromocytoma presentation in 6.1% of cases. Clinical
symptomps attributable to pheochromocytoma were
present in 61% of patients (9). The presented case
confirms the importance of this clinical manifestation
in systemic advanced NF1. 
Since there is no reliable genetic test to define the
possible phenotypic expression of different genomic
patterns, it is evident the necessity of a strict follow-up
in NF1 patients in order to identify precocious clini-
cal signs of extra-cutaneous diseases. 
Furthermore several reports describe the presence
of intestinal neurofibromas in advanced neurofibro-
matosis. Visceral tumours arising in the neural plexus
of the intestinal wall may cause ulceration, bleeding,
obstruction, perforation and palpable abdominal
mass (17-20). Involvement of other visceral structures
(vessels, urinary bladder) has been also described (21,
22).
These conditions, often symptomatic or sometimes
found intraoperatively for other disorders, may requi-
re surgery to be solved. 
Conclusions
The presented clinical case is a typical example o
possible multiple systemic involvement of advanced
NF1, in which cutaneous disease was associated to
adrenal medulla neoplasia and intestinal disease.
In conclusion variability in clinical presentation of
NF1, with possible manifestation of severe systemic
benign and malignant diseases, requires strict follow-
up and programs of specific screening in order to ob-
tain precocious diagnosis of extra-cutaneous lesions. 
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Fig. 3 - MIBG scintigraphy reveals ipercaptation by left adrenal medulla.
Fig. 4 - Intraoperative view of the jejunal neurofibroma.
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